A method for extracting rabodiin M

By employing proteolytic enzyme hydrolysis and natural eutectic solvent washing technology, the problem of impurity removal in the extraction of riboboroside M was solved, improving the crystallization yield and purity, and achieving a green and environmentally friendly extraction process.

CN123106790APending Publication Date: 2026-11-17DONGTAI HAORUI BIOTECHNOLOGY CO LTD
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202611182764.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-08-05
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing technologies for extracting riboside M are difficult to remove impurities, resulting in low crystallization yield, insufficient purity, and are environmentally unfriendly.

Method used

The large molecular proteins in the biotransformation solution were removed by enzymatic hydrolysis, combined with cooling crystallization and washing with a natural eutectic solvent. Through high-temperature enzyme inactivation, anti-solvent regulation and pure seed induction, efficient crystallization of riboside M was achieved.

Benefits of technology

This method improves the crystallization yield and purity of riboboroside M, solves the problem of impurity removal, and reduces environmental pollution by using environmentally friendly solvents.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

This invention discloses a method for extracting ribobadiol M, belonging to the field of separation and purification technology. The method for extracting ribobadiol M includes the following steps: adding a protease to a biotransformation solution containing ribobadiol M for enzymatic hydrolysis; after hydrolysis, inactivating the enzyme at high temperature; filtering to obtain an enzymatic hydrolysis filtrate; cooling and crystallizing the enzymatic hydrolysis filtrate; maintaining the temperature to allow crystal growth; filtering to obtain crude ribobadiol M crystals; mixing the crude ribobadiol M crystals with a natural eutectic solvent; stirring and washing; filtering to obtain ribobadiol M crystals; rinsing the ribobadiol M crystals with a rinsing solution and drying to obtain the finished ribobadiol M product. This invention uses a natural eutectic solvent to wash and purify the crude ribobadiol M crystals. Impurities in the crude ribobadiol M crystals dissolve in the natural eutectic solvent, while ribobadiol M remains in the solid-phase crystals, effectively improving the purity and yield of ribobadiol M crystals.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of separation and purification technology, and in particular to a method for extracting riboflavin M. Background Technology

[0002] Reb M is a natural steviol glycoside with a pure sweetness, no aftertaste, and zero calories, and is considered one of the best natural sweeteners in terms of overall quality. However, the natural content of Reb M in dried stevia leaves is usually less than 0.1 wt%, and traditional extraction methods are costly and have low yields, making it difficult to meet the growing market demand.

[0003] In recent years, significant progress has been made in the enzymatic conversion of Reb A to Reb M using engineered strains of Escherichia coli. This method typically employs recombinant bacteria to express glycosyltransferases (UGTs) and sucrose synthase (SuSy), catalyzing the conversion of Reb A to Reb M in the form of crude enzyme solution (centrifuged supernatant of recombinant bacterial lysate), thus obtaining a conversion solution containing Reb M. However, this method has the following problems: (1) The conversion solution contains a large number of bacterial fragments, proteins, and byproducts, which are easily trapped inside the Reb M lattice during crystallization, affecting the purity and food safety of the Reb M product. Traditional protein removal methods (such as heating precipitation, acid precipitation, etc.) can easily lead to the degradation or loss of Reb M. (2) When using organic solvents (such as methanol, ethanol) to extract Reb M crystals from the conversion solution, the Reb M crystallization yield is low, the purity is insufficient, and a large amount of organic waste liquid is generated, which is not environmentally friendly. Summary of the Invention

[0004] In view of this, the purpose of the present invention is to provide a method for extracting riboflavin M, which overcomes the problems of difficult removal of impurities, low crystallization yield, insufficient purity and environmental unfriendliness of riboflavin M in the extraction of riboflavin M in the prior art.

[0005] In a first aspect, the present invention provides a method for extracting rebaudioside M, comprising the following steps: Add protease to the biotransformation solution containing ribobandin M for enzymatic hydrolysis. After enzymatic hydrolysis, inactivate the enzyme by high temperature and filter to obtain the enzymatic hydrolysis filtrate. The enzymatic hydrolysis filtrate was cooled and crystallized at a rate of 5℃ / h-15℃ / h to 10℃-15℃, then kept at the temperature to allow crystal growth, and filtered to obtain crude crystals of Rebadinoside M. The crude crystals of Rebaudioside M were mixed with a natural eutectic solvent, stirred, washed, and filtered to obtain Rebaudioside M crystals. The Rebaudioside M crystals were then rinsed with a rinsing solution and dried to obtain the finished Rebaudioside M product.

[0006] Compared with existing technologies, this invention first uses proteases to degrade large-molecule proteins in the biotransformation solution into small-molecule peptides and amino acids. After high-temperature enzyme inactivation, insoluble solid impurities are removed by filtration, followed by cooling crystallization to obtain crude rectonidin M crystals. Then, the crude rectonidin M crystals are washed and purified using a natural eutectic solvent, dissolving impurities in the crude rectonidin M crystals in the natural eutectic solvent, while rectonidin M remains in the solid-phase crystals. After washing, the solid-phase crystals are collected by filtration to obtain rectonidin M crystals. Finally, the rectonidin M crystals are rinsed and dried to further remove residual natural eutectic solvent, yielding the finished rectonidin M product. In the washing and purification of the crude rectonidin M crystals, this invention uses a natural eutectic solvent instead of traditional organic solvents, which not only solves the environmental problem of traditional organic solvents but also further improves the purity and yield of rectonidin M crystals.

[0007] Furthermore, the amount of protease added is 0.1wt%-2wt% of the total protein content in the biotransformation solution, the temperature during enzymatic hydrolysis is 40℃-65℃, and the pH value during enzymatic hydrolysis is 6.5-8.5.

[0008] In the above technical solution, under the conditions of the above-mentioned addition amount, suitable temperature and pH value, the protease can decompose the impurities in the bioconversion solution into small molecule peptides and amino acids, effectively avoiding the interference of impurities on the subsequent cooling crystallization process, resulting in a higher yield, higher purity and more regular crystal morphology of the crude product of riboside M crystals.

[0009] Furthermore, the conditions for high-temperature enzyme inactivation are: incubation at 90℃-100℃ for 15-30 minutes.

[0010] In the above technical solution, under the conditions of high-temperature enzyme inactivation, the protease can be denatured and inactivated, and a small amount of unhydrolyzed macromolecular proteins and some polypeptides in the enzymatic hydrolysate will be denatured and aggregated by heat to form flocculent precipitates, which will be filtered out in subsequent steps. This further removes protein impurities in the biotransformation solution before cooling and crystallization, ensuring the crystallization effect of Rebaudioside M.

[0011] Furthermore, the protease includes at least one of alkaline protease, neutral protease, and papain.

[0012] Furthermore, before cooling and crystallizing, an antisolvent is added to the enzymatic hydrolysis filtrate, the amount of which is 5%-10% of the volume of the enzymatic hydrolysis filtrate; and / or, the antisolvent includes at least one of anhydrous ethanol and isopropanol.

[0013] In the above technical solution, adding the antisolvent to the enzymatic hydrolysis filtrate can further reduce the solubility of ribobadiin M in the enzymatic hydrolysis filtrate, making ribobadiin M easier to crystallize and precipitate. At the same time, the antisolvent can also regulate the growth morphology of ribobadiin M crystals and reduce the inclusion of impurities in the crystal lattice.

[0014] Furthermore, when the enzymatic hydrolysate is cooled and crystallized, the process also includes: when the temperature is lowered to 20℃-30℃, adding pure Rebaudioside M seed crystals to the enzymatic hydrolysate, wherein the amount of pure Rebaudioside M seed crystals added is 0.5wt%-5wt% of the Rebaudioside M content in the enzymatic hydrolysate.

[0015] In the above technical solution, adding an appropriate amount of pure Rebaudioside M seed crystals during a specific time period of cooling crystallization can provide regular lattice growth sites, controllably consume the supersaturation of the system, suppress the instantaneous burst of a large number of fine crystals, induce the generation of rod-shaped crystals with large particles and uniform morphology, reduce the lattice inclusion of polypeptide impurities, and improve the crystallization purity.

[0016] Furthermore, the cooling crystallization and heat preservation crystal growth processes are accompanied by stirring at 50 rpm to 200 rpm; and / or, the heat preservation crystal growth time is 2 h to 6 h.

[0017] In the above technical solution, the cooling crystallization and heat preservation crystal growth processes are accompanied by stirring at 50rpm-200rpm, which can make the crystal grains uniformly suspended in the liquid phase, homogenize the internal temperature and solute concentration of the system, update the mass transfer environment at the solid-liquid interface of the crystal, and promote the regular growth of the crystal.

[0018] Furthermore, the natural eutectic solvent includes hydrogen bond acceptor, hydrogen bond donor and deionized water, with a molar ratio of 1:(1-2):(0.5-1).

[0019] The above technical solution mixes hydrogen bond acceptors, hydrogen bond donors, and deionized water in a specific molar ratio to obtain a natural eutectic solvent. A hydrogen bond network of specific polarity is constructed in the natural eutectic solvent. Impurities such as peptides, amino acids, pigments, and glycosides in the crude crystalline product of rebaudioside M are complexed and dissolved by the hydrogen bond network of the natural eutectic solvent and enter the solvent liquid phase. However, the highly glycosylated molecule of rebaudioside M has a large molecular volume and significant steric hindrance, making it difficult for the natural eutectic solvent to destroy the crystal lattice structure and dissolve rebaudioside M. This allows rebaudioside M to remain stably in the solid crystalline phase, thereby achieving efficient separation and purification of rebaudioside M from various impurities in the crude crystalline product.

[0020] Furthermore, hydrogen bond acceptors include at least one of choline chloride and betaine.

[0021] Furthermore, the hydrogen bond donor includes at least one of glycolic acid, lactic acid, sorbitol, citric acid, and malic acid.

[0022] The hydrogen bond acceptors and hydrogen bond donors selected in the above technical solutions can further enhance the selectivity of natural eutectic solvents, reduce the loss of rebaudioside M, and further improve the purity and yield of rebaudioside M crystals.

[0023] Furthermore, the mass-to-volume ratio of crude rabodiin M crystals to a natural eutectic solvent is 1 g:(5 mL-12 mL), the stirring and washing temperature is 45℃-55℃, the stirring speed is 200 rpm-300 rpm, and the stirring and washing time is 2 h-4 h; and / or, the washing solution is water or ethanol. Detailed Implementation

[0024] To make the technical problems to be solved, the technical solutions, and the beneficial effects of the present invention clearer, the present invention will be further described in detail below with reference to specific embodiments. It should be understood that the specific embodiments described herein are only for explaining the present invention and are not intended to limit the present invention.

[0025] In a first aspect, embodiments of the present invention provide a method for extracting rebaudioside M, comprising the following steps: S1. Add protease to the biotransformation solution containing riboflavin M for enzymatic hydrolysis. After enzymatic hydrolysis, inactivate the enzyme by high temperature, filter, and obtain the enzymatic hydrolysate.

[0026] The preparation method of the biotransformation solution containing riboflavin M in the above steps can be referred to as follows: Take stevia extract (containing 85wt% ribobandi glycoside A) and dissolve it in 100 mM phosphate buffer to a final concentration of 60 g / L-80 g / L. Add sucrose (4 times the mass of stevia extract), UDP (to a final concentration of 0.5 g / L), and then add OD (to a final concentration of 0.5 g / L). 600 Crude enzyme solution of glycosyltransferase UGT91C1 with a final concentration of OD30 600 The crude enzyme solution of glycosyltransferase UGT76G4 with a concentration of 10 and a final OD concentration 600 A crude enzyme solution of 20% sucrose synthase (the preparation method of the crude enzyme solution is described in patent CN119265153B) was used to catalyze the reaction of rebaudioside A to rebaudioside M at a pH of 6.5-7.2 and a temperature of 35℃-40℃ for 20-30 hours, resulting in a reaction solution containing rebaudioside M (Reb M). Purified water was added to the above reaction solution for dilution, with a volume ratio of reaction solution to purified water of 1:(0.5-1). The enzyme was then inactivated by heating to 90℃-95℃ for 15-20 minutes. Insoluble impurities were removed by heat filtration using a 15μm pore size filter membrane, and the filtrate was collected. This filtrate is the biotransformation solution containing rebaudioside M.

[0027] Tests showed that the content of ribodilin M in the above-mentioned conversion solution containing ribodilin M was 30 g / L-55 g / L, the total protein content was 2 g / L-5 g / L, and the pH value was 6-7.

[0028] In the above steps, the amount of protease added is 0.1wt%-2wt% of the total protein content in the biotransformation solution, the enzymatic hydrolysis temperature is 40℃-65℃, the pH value during enzymatic hydrolysis is 6.5-8.5, and the hydrolysis time is 0.5h-6h. For example, the amount of protease added can be 0.1wt%, 0.5wt%, 1wt%, 1.5wt%, or 2wt% of the total protein content in the biotransformation solution; the enzymatic hydrolysis temperature can be 40℃, 45℃, 50℃, 55℃, 60℃, or 65℃; and the pH value during enzymatic hydrolysis can be 6.5, 7, 7.5, 8, or 8.5.

[0029] The protease can be selected from at least one of alkaline protease, neutral protease, and papain, preferably Bacillus subtilis alkaline protease.

[0030] Under the above enzymatic hydrolysis conditions, the above-mentioned protease is used to enzymatically hydrolyze the bioconversion solution containing riboside M, which can decompose the impurities in the bioconversion solution into small molecule peptides and amino acids, thus avoiding interference from impurities in the subsequent cooling and crystallization process.

[0031] In the above steps, the conditions for high-temperature enzyme inactivation are: incubation at 90℃-100℃ for 15min-30min. For example, the temperature for high-temperature enzyme inactivation can be 90℃, 95℃, or 100℃; the incubation time can be 15min, 20min, 25min, or 30min.

[0032] After the enzyme inactivation at high temperature, the protease and a small amount of incompletely hydrolyzed impurities in the biotransformation solution denature due to heat and form flocculent precipitates. At this time, the biotransformation solution is subjected to vacuum filtration or plate and frame filtration to separate the solid and liquid components, remove the denatured protein precipitates and other insoluble impurities, and obtain the enzymatic hydrolysis filtrate.

[0033] S2. The enzymatic hydrolysis filtrate is cooled and crystallized at a cooling rate of 5℃ / h-15℃ / h to 10℃-15℃, then kept at the temperature to allow crystal growth, and filtered to obtain crude crystals of riboside M.

[0034] For example, during the cooling crystallization process described above, the temperature can be reduced to 10℃, 12℃, or 15℃ at a cooling rate of 5℃ / h, 10℃ / h, or 15℃ / h.

[0035] In the above steps, the heat preservation and crystal growth time is 2h-6h. For example, the heat preservation and crystal growth time can be 2h, 4h or 6h.

[0036] By cooling crystallization and heat preservation crystal growth, riboside M in the enzymatic hydrolysis filtrate can be fully crystallized out. Then, solid-liquid separation is carried out by vacuum filtration or plate and frame filtration to obtain crude riboside M crystals.

[0037] Furthermore, the above steps involve stirring at 50 rpm to 200 rpm during both the cooling crystallization and heat preservation crystal growth processes. For example, the stirring speed can be 50 rpm, 100 rpm, 120 rpm, or 200 rpm.

[0038] In some embodiments, to promote the crystallization of ribobadiol M, an antisolvent can be added to the enzymatic hydrolysis filtrate before cooling and crystallization. The amount of antisolvent added is 5%-10% of the volume of the enzymatic hydrolysis filtrate. The antisolvent can be at least one of anhydrous ethanol and isopropanol.

[0039] In some embodiments, in order to regulate the crystallization particle size distribution and improve crystal purity, pure seed crystals of ribobadiol M can be added to the enzymatic hydrolysis filtrate when the temperature is lowered to 20°C-30°C.

[0040] Preferably, the pure seed crystals of riboside M are added when the temperature is cooled to 10-15°C above the final crystallization temperature; the purity of the pure seed crystals of riboside M is ≥98wt%.

[0041] The amount of pure Rebaudioside M seed crystals added is 0.5wt%-5wt% of the Rebaudioside M content in the enzymatic hydrolysis filtrate. For example, the amount of pure Rebaudioside M seed crystals added can be 0.5wt%, 1wt%, 2wt%, 3wt%, 4wt%, or 5wt% of the Rebaudioside M content in the enzymatic hydrolysis filtrate.

[0042] After the above-mentioned cooling crystallization and heat preservation crystal growth process, the purity of the crude crystalline product of riboside M is 80wt%-88wt%.

[0043] S3. Mix the crude crystals of Rebaudioside M with a natural eutectic solvent, stir, wash, and filter to obtain Rebaudioside M crystals. Rinse the Rebaudioside M crystals with a rinsing solution and then dry to obtain the finished Rebaudioside M product.

[0044] The natural eutectic solvent in the above steps includes a hydrogen bond acceptor, a hydrogen bond donor, and deionized water, with a molar ratio of 1:(1-2):(0.5-1). For example, the molar ratio of hydrogen bond acceptor, hydrogen bond donor, and deionized water can be 1:1:0.5, 1:1.5:0.5, 1:2:0.5, or 1:2:1.

[0045] In some embodiments, the hydrogen bond acceptor may be at least one of choline chloride and betaine.

[0046] In other embodiments, the hydrogen bond donor may be selected from at least one of glycolic acid, lactic acid, sorbitol, citric acid, and malic acid.

[0047] The crude crystals of ribobadiin M were washed using the aforementioned natural eutectic solvent. By utilizing the difference in affinity between the natural eutectic solvent and ribobadiin M and impurities, the target product ribobadiin M was "repelled" while the impurities were "attracted". Impurities (pigments, small peptides, amino acids, glycosides, etc.) were drawn into the solvent phase, while ribobadiin M remained in the solid crystals.

[0048] Compared with traditional volatile organic solvents, natural eutectic solvents have advantages such as being environmentally friendly, less polluting, and safer, enabling the green separation and purification of ribobandibidine M. Furthermore, natural eutectic solvents can be recycled after washing, further reducing production costs and meeting the requirements of green chemistry and clean production.

[0049] Furthermore, the mass-to-volume ratio of crude rabodiin M crystals to natural eutectic solvent was 1 g:(5 mL-12 mL), the stirring and washing temperature was 45℃-55℃, the stirring speed was 200 rpm-300 rpm, and the stirring and washing time was 2 h-4 h.

[0050] For example, the mass-to-volume ratio of crude rabodiin M crystals to a natural eutectic solvent can be 1 g:5 mL, 1 g:8 mL, 1 g:10 mL, or 1 g:12 mL; the stirring and washing temperature can be 45°C, 50°C, or 55°C; the stirring speed can be 200 rpm, 250 rpm, or 300 rpm; and the stirring and washing time can be 2 h, 3 h, or 4 h.

[0051] Furthermore, after the crude rectoboroside M crystals are washed and filtered with a natural eutectic solvent to obtain rectoboroside M crystals, water or ethanol can be used to rinse the rectoboroside M crystals. The natural eutectic solvent with the specific composition and ratio described above in this invention has a low viscosity and can be easily rinsed away without any risk of residue.

[0052] After rinsing, the drying method for Rebaudioside M crystals can be selected as follows: vacuum drying for 4h-6h at a temperature of 40℃-60℃ and a vacuum degree of -0.085MPa to -0.1MPa. The purity of the obtained Rebaudioside M product can reach more than 95wt%, which meets the food additive standards of major global markets.

[0053] It should be understood that, unless otherwise specified, all raw materials used in the following examples are commercially available.

[0054] The biotransformation solutions containing ribavirin M in the following examples were all prepared using the following method: Stevia extract (containing 85 wt% ribobandi glycoside A) was dissolved in 100 mM phosphate buffer (pH 7.0) to a final concentration of 70 g / L. Four times the mass of sucrose (containing ribobandi glycoside A) and UDP (to a final concentration of 0.5 g / L) were then added. Finally, OD (to a final concentration of 70 g / L) was added. 600 Crude enzyme solution of glycosyltransferase UGT91C1 with a final concentration of OD30 600 The crude enzyme solution of glycosyltransferase UGT76G4 with a concentration of 10 and a final OD concentration 600 A crude enzyme solution of 20% sucrose synthase (the preparation method of the crude enzyme solution is referred to in patent CN119265153B) was used to catalyze the reaction of rebaudioside A to generate rebaudioside M under the conditions of pH 7.0 and temperature 37℃. After 24 hours of reaction, a reaction solution containing rebaudioside M (Reb M) was obtained.

[0055] Dilute the above reaction solution with purified water at a volume ratio of 1:0.5. Then, heat to 95°C and incubate for 15 min to inactivate the enzyme. Remove insoluble impurities by heat filtration using a 15 μm pore size filter membrane and collect the filtrate, which is the biotransformation solution containing riboside M.

[0056] The test results showed that the content of ribodilin M in the above-mentioned conversion solution containing ribodilin M was 40 g / L, the total protein content was 3 g / L, and the pH value was 7.0.

[0057] Example 1 S1, enzymatically hydrolyzed miscellaneous proteins Take 1 L of biotransformation solution containing ribobandiidine M, and add Bacillus subtilis alkaline protease for enzymatic hydrolysis. The amount of Bacillus subtilis alkaline protease added is 1.0 wt% of the total protein content in the biotransformation solution. Hydrolysis is carried out at 55℃ and pH 8.0 for 2 h to degrade the large protein molecules in the biotransformation solution into small peptides and amino acids. After hydrolysis, the resulting hydrolysate is heated to 95℃ and incubated for 15 min for high-temperature enzyme inactivation. Then, it is vacuum filtered under a vacuum of -0.09 MPa (pore size 15 μm) to remove insoluble impurities, and the hydrolysate is collected.

[0058] S2, Cooling crystallization The enzymatic hydrolysis filtrate was placed in a crystallization tank and cooled to 12°C at a rate of 10°C / h, then kept at this temperature for 4 hours to allow ribobandiside M to crystallize out. When the temperature reached 25°C, pure ribobandiside M seed crystals (purity ≥98wt%) were added, at a rate of 2wt% of the ribobandiside M content in the enzymatic hydrolysis filtrate. Stirring was performed at 100 rpm during both the cooling and crystallization processes. After crystallization, vacuum filtration was performed under a vacuum of -0.09 MPa with a pore size of 10 μm to obtain crude ribobandiside M crystals. HPLC analysis showed that the purity of the crude ribobandiside M crystals was 85wt%.

[0059] S3, natural eutectic solvent washing and impurity removal A natural eutectic solvent was prepared by mixing choline chloride, glycolic acid, and deionized water in a molar ratio of 1:1.5:0.5.

[0060] The crude crystalline product of ribobandiside M was mixed with the aforementioned natural eutectic solvent at a ratio of 1 g: 8 mL. The mixture was stirred and washed at 250 rpm for 3 hours at 50 °C. After washing, the mixture was vacuum filtered under a vacuum of -0.09 MPa with a pore size of 10 μm to obtain ribobandiside M crystals. The ribobandiside M crystals were then rinsed with pure water at 4 °C, using 0.8 mL of pure water per gram of ribobandiside M crystals. The rinsed ribobandiside M crystals were then vacuum dried at 60 °C under a vacuum of -0.09 MPa for 4 hours to obtain the finished ribobandiside M product. HPLC analysis showed that the purity of the finished ribobandiside M product was 97.5 wt%, and the overall yield was 85.1%.

[0061] Example 2 S1, enzymatically hydrolyzed miscellaneous proteins Take 1 L of biotransformation solution containing ribobandibidine M, and add neutral protease for enzymatic hydrolysis. The amount of neutral protease added is 0.5 wt% of the total protein content in the biotransformation solution. Hydrolysis is carried out at 45℃ and pH 7.0 for 3 h to degrade the large protein molecules in the biotransformation solution into small peptides and amino acids. After hydrolysis, the resulting hydrolysate is heated to 95℃ and incubated for 15 min for high-temperature enzyme inactivation. Then, it is vacuum filtered under a vacuum of -0.09 MPa (pore size 10 μm) to remove insoluble impurities, and the hydrolysate is collected.

[0062] S2, Cooling crystallization The enzymatic hydrolysis filtrate was placed in a crystallization tank and cooled to 10°C at a rate of 5°C / h, then kept at this temperature for 6 hours to allow riboflavin M to crystallize out. When the temperature reached 25°C, pure riboflavin M seed crystals (purity ≥98wt%) were added, at a rate of 1wt% of the riboflavin M content in the enzymatic hydrolysis filtrate. Stirring was performed during both the cooling and crystallization processes at a speed of 60 rpm. After crystallization, vacuum filtration was performed under a vacuum of -0.09 MPa with a pore size of 10 μm to obtain crude riboflavin M crystals. HPLC analysis showed that the purity of the crude riboflavin M crystals was 83.9wt%.

[0063] S3, natural eutectic solvent washing and impurity removal A natural eutectic solvent was prepared by mixing choline chloride, lactic acid, and deionized water in a molar ratio of 1:2:0.5.

[0064] The crude crystalline product of ribobandiside M was mixed with the aforementioned natural eutectic solvent at a ratio of 1 g: 5 mL. The mixture was stirred and washed at 200 rpm for 4 h at 45 °C. After washing, vacuum filtration was performed under a vacuum of -0.1 MPa with a pore size of 15 μm to obtain ribobandiside M crystals. The ribobandiside M crystals were then rinsed with pure water at 4 °C, using 1.0 mL of pure water per gram of ribobandiside M crystals. The rinsed ribobandiside M crystals were then vacuum dried at 60 °C under a vacuum of -0.085 MPa for 5 h to obtain the finished ribobandiside M product. HPLC analysis showed that the purity of the finished ribobandiside M product was 95.2 wt%, and the total yield was 89.8%.

[0065] Example 3 S1, enzymatically hydrolyzed miscellaneous proteins Take 1 L of biotransformation solution containing riboflavin M, and add papain to perform enzymatic hydrolysis. The amount of papain added is 1.5 wt% of the total protein content in the biotransformation solution. Hydrolysis is carried out at 60℃ and pH 6.5 for 1.5 h to degrade the large protein molecules in the biotransformation solution into small peptides and amino acids. After hydrolysis, the resulting hydrolysate is heated to 95℃ and incubated for 15 min for high-temperature enzyme inactivation. Then, it is vacuum filtered under a vacuum of -0.085 MPa (pore size 20 μm) to remove insoluble impurities, and the hydrolysate is collected.

[0066] S2, Cooling crystallization The enzymatic hydrolysis filtrate was placed in a crystallization tank and cooled to 15°C at a rate of 15°C / h, then kept at this temperature for 3 hours to allow riboflavin M to crystallize out. When the temperature reached 30°C, pure riboflavin M seed crystals (purity ≥98wt%) were added, at a rate of 2wt% of the riboflavin M content in the enzymatic hydrolysis filtrate. Stirring was performed during both the cooling and crystallization processes at a speed of 120 rpm. After crystallization, vacuum filtration was performed under a vacuum of -0.09 MPa with a pore size of 15 μm to obtain crude riboflavin M crystals. HPLC analysis showed that the purity of the crude riboflavin M crystals was 84.7wt%.

[0067] S3, natural eutectic solvent washing and impurity removal A natural eutectic solvent was prepared by mixing betaine, citric acid, and deionized water in a molar ratio of 1:1:0.5.

[0068] The crude crystalline product of ribobandiside M was mixed with the aforementioned natural eutectic solvent at a ratio of 1 g: 12 mL. The mixture was stirred and washed at 300 rpm for 2 h at 55 °C. After washing, vacuum filtration was performed under a vacuum of -0.1 MPa with a pore size of 10 μm to obtain ribobandiside M crystals. The ribobandiside M crystals were then washed with ethanol at 4 °C, using 1.5 mL of ethanol per gram of ribobandiside M crystals. The washed ribobandiside M crystals were then vacuum dried at 60 °C under a vacuum of -0.085 MPa for 5 h to obtain the finished ribobandiside M product. HPLC analysis showed that the purity of the finished ribobandiside M product was 96.8 wt%, and the total yield was 83.6%.

[0069] Example 4 S1, enzymatically hydrolyzed miscellaneous proteins Take 1 L of biotransformation solution containing ribobandiidine M, and add Bacillus subtilis alkaline protease for enzymatic hydrolysis. The amount of Bacillus subtilis alkaline protease added is 0.1 wt% of the total protein content in the biotransformation solution. Hydrolysis is carried out at 65℃ and pH 8.5 for 2 h to degrade the large protein molecules in the biotransformation solution into small peptides and amino acids. After hydrolysis, the resulting hydrolysate is heated to 95℃ and incubated for 15 min for high-temperature enzyme inactivation. Then, it is vacuum filtered under a vacuum of -0.085 MPa (pore size 20 μm) to remove insoluble impurities, and the hydrolysate is collected.

[0070] S2, Cooling crystallization The enzymatic hydrolysis filtrate was placed in a crystallization tank, and 5% (by volume) of isopropanol was added. The temperature was lowered to 12°C at a rate of 10°C / h, and then maintained at this temperature for 4 hours to allow riboflavin M to crystallize out. When the temperature reached 25°C, pure riboflavin M seed crystals (purity ≥98wt%) were added, with the amount of pure riboflavin M seed crystals being 0.5wt% of the riboflavin M content in the enzymatic hydrolysis filtrate. Stirring was performed during both the cooling and crystallization processes at a speed of 200 rpm. After crystallization, vacuum filtration was performed under a vacuum of -0.085 MPa with a pore size of 20 μm to obtain crude riboflavin M crystals. HPLC analysis showed that the purity of the crude riboflavin M crystals was 82.7wt%.

[0071] S3, natural eutectic solvent washing and impurity removal A natural eutectic solvent was prepared by mixing choline chloride, sorbitol, and deionized water in a molar ratio of 1:1:0.5.

[0072] The crude crystalline product of ribobandiside M was mixed with the aforementioned natural eutectic solvent at a ratio of 1 g: 10 mL. The mixture was stirred and washed at 250 rpm for 3 h at 50 °C. After washing, the mixture was vacuum filtered under a vacuum of -0.085 MPa with a pore size of 15 μm to obtain ribobandiside M crystals. The ribobandiside M crystals were then washed with ethanol at 4 °C, using 0.8 mL of ethanol per gram of ribobandiside M crystals. The washed ribobandiside M crystals were then vacuum dried at 60 °C under a vacuum of -0.09 MPa for 4 h to obtain the finished ribobandiside M product. HPLC analysis showed that the purity of the finished ribobandiside M product was 96.0 wt%, and the total yield was 84.5%.

[0073] Example 5 S1, enzymatically hydrolyzed miscellaneous proteins Take 1 L of biotransformation solution containing ribobandibidine M, add neutral protease to perform enzymatic hydrolysis, the amount of neutral protease added is 2 wt% of the total protein content in the biotransformation solution. Hydrolyze for 3 h at 40℃ and pH 7.5 to degrade the large protein molecules in the biotransformation solution into small peptides and amino acids. After hydrolysis, heat the resulting hydrolysate to 95℃ and incubate for 15 min for high-temperature enzyme inactivation. Then, perform vacuum filtration under a vacuum of -0.09 MPa (pore size 10 μm) to remove insoluble impurities and collect the hydrolysate.

[0074] S2, Cooling crystallization The enzymatic hydrolysis filtrate was placed in a crystallization tank, and anhydrous ethanol (10% of the filtrate volume) was added. The temperature was lowered to 10°C at a rate of 5°C / h, and then maintained at this temperature for 6 hours to allow riboflavin M to crystallize out. When the temperature dropped to 25°C, pure riboflavin M seed crystals (purity ≥98wt%) were added, with the amount of pure riboflavin M seed crystals being 5wt% of the riboflavin M content in the enzymatic hydrolysis filtrate. Stirring was performed during both the cooling and crystallization processes at a speed of 50 rpm. After crystallization, vacuum filtration was performed under a vacuum of -0.09 MPa with a pore size of 15 μm to obtain crude riboflavin M crystals. HPLC analysis showed that the purity of the crude riboflavin M crystals was 84.2wt%.

[0075] S3, natural eutectic solvent washing and impurity removal A natural eutectic solvent was prepared by mixing betaine, malic acid, and deionized water in a molar ratio of 1:2:1.

[0076] The crude crystalline product of ribobandiside M was mixed with the aforementioned natural eutectic solvent at a ratio of 1 g: 5 mL. The mixture was stirred and washed at 200 rpm for 4 h at 45 °C. After washing, vacuum filtration was performed under a vacuum of -0.09 MPa with a pore size of 15 μm to obtain ribobandiside M crystals. The ribobandiside M crystals were then rinsed with pure water at 4 °C, using 1.0 mL of pure water per gram of ribobandiside M crystals. The rinsed ribobandiside M crystals were then vacuum dried at 60 °C under a vacuum of -0.09 MPa for 5 h to obtain the finished ribobandiside M product. HPLC analysis showed that the purity of the finished ribobandiside M product was 94.8 wt%, and the overall yield was 85.2%.

[0077] Example 6 The method of Example 1 was used to extract riboside M from the biotransformation solution, except that pure riboside M seed crystals were not added during cooling crystallization. HPLC analysis showed that the purity of the crude riboside M crystals in this example was 78.5 wt%, and the purity of the final riboside M product was 93.5 wt%, with a total yield of 84.2%.

[0078] Comparative Example 1 Rebaudioside M contained in the biotransformation solution was extracted according to the method of Example 1, except that the natural eutectic solvent was replaced by an equal amount of the organic solvent ethanol. HPLC analysis showed that the purity of the obtained rebaudioside M product was 89.5 wt%, and the overall yield was 77.3%.

[0079] Comparative Example 2 Rebaudioside M contained in the biotransformation solution was extracted according to the method of Example 1, with the only difference being the composition of the natural eutectic solvent. In this comparative example, the natural eutectic solvent consisted of choline chloride, lactic acid, oxalic acid, and glycerol in a molar ratio of 2:2:1:1. HPLC analysis showed that the purity of the obtained rebaudioside M product was 91.2 wt%, and the overall yield was 78.5%.

[0080] Comparative Example 3 Rebaudioside M contained in the biotransformation solution was extracted according to the method of Example 1, except that the hydrogen bond acceptor choline chloride was replaced with an equal amount of hydrogen bond acceptor urea. HPLC analysis showed that the purity of the obtained rebaudioside M product was 89.8 wt%, and the total yield was 80.1%.

[0081] Comparative Example 4 Rebaudioside M contained in the biotransformation solution was extracted according to the method of Example 1, except that the hydrogen bond donor glycolic acid was replaced with an equal amount of hydrogen bond donor glycerol. HPLC analysis showed that the purity of the obtained rebaudioside M product was 87.1 wt%, and the overall yield was 79.6%.

[0082] Comparative Example 5 The method of Example 3 was used to extract ribobandi glycoside M from the biotransformation solution, with the only difference being that the molar ratio of betaine, citric acid, and deionized water in the natural eutectic solvent was 1:0.5:0.5. HPLC analysis showed that the purity of the obtained ribobandi glycoside M product was 85.8 wt%, and the total yield was 81.7%.

[0083] Comparative Example 6 Rebaudioside M contained in the biotransformation solution was extracted according to the method in Example 5, the only difference being that the molar ratio of betaine, malic acid, and deionized water in the natural eutectic solvent was 1:3:2. HPLC analysis showed that the purity of the obtained rebaudioside M product was 88.5 wt%, and the total yield was 80.7%.

[0084] The HPLC detection conditions in Examples 1 to 6 and Comparative Examples 1 to 6 above are as follows: Chromatographic column: C18 column (4.6 mm × 250 mm, 5 μm); mobile phase: gradient elution with sodium dihydrogen phosphate buffer (pH adjusted to 2.7 with phosphoric acid) as the aqueous phase and acetonitrile as the organic phase.

[0085] Gradient elution program: 0 min-30 min, the volume percentage of sodium dihydrogen phosphate buffer is linearly reduced from 65% to 50%, and the volume percentage of acetonitrile is increased from 35% to 50%; 30.1 min-45 min, the volume percentage of sodium dihydrogen phosphate buffer is linearly increased from 50% to 65%, and the volume percentage of acetonitrile is reduced from 50% to 35%.

[0086] Flow rate: 1.0 mL / min; Detection wavelength: 210 nm; Column temperature: 45℃; Injection volume: 10 μL.

[0087] Detector: Ultraviolet detector.

[0088] Quantitative method: External standard method.

[0089] The purity and yield of the final product of riboside M obtained from Examples 1 to 6 and Comparative Examples 1 to 6 show that: In Comparative Example 1, when the natural eutectic solvent was replaced by an equal amount of the organic solvent ethanol, the purity and yield of the riboboroside M product both decreased, indicating that compared to organic solvents, the natural eutectic solvent of the present invention can improve the purity and yield of the riboboroside M product.

[0090] In Comparative Examples 2, 3, and 4, the purity and yield of the riboside M product decreased after the composition of the natural eutectic solvent was changed. This indicates that the natural eutectic solvent with a specific composition of the present invention can further improve the purity and yield of the riboside M product.

[0091] After the composition ratio of the natural eutectic solvent was changed in Comparative Examples 5 and 6, the purity and yield of the riboside M product both decreased, indicating that the natural eutectic solvent with a specific ratio of the present invention can further improve the purity and yield of the riboside M product.

[0092] The above description is merely a preferred embodiment of the present invention and is not intended to limit the present invention. Although the present invention has been described in detail with reference to the foregoing embodiments, those skilled in the art can still modify the technical solutions described in the foregoing embodiments or make equivalent substitutions for some of the technical features. Any modifications, equivalent substitutions, improvements, etc., made within the spirit and principles of the present invention should be included within the protection scope of the present invention.

Claims

1. A method for extracting riboflavin M, characterized in that, Includes the following steps: Add protease to the biotransformation solution containing ribobandin M for enzymatic hydrolysis. After enzymatic hydrolysis, inactivate the enzyme by high temperature and filter to obtain the enzymatic hydrolysis filtrate. The enzymatic hydrolysate was subjected to cooling crystallization at a cooling rate of 5℃ / h-15℃ / h to 10℃-15℃, then kept at the temperature to allow crystal growth, and filtered to obtain crude crystalline product of riboside M. The crude crystalline product of riboside M is mixed with a natural eutectic solvent, stirred, washed, and filtered to obtain riboside M crystals. The riboside M crystals are then rinsed with a rinsing solution and dried to obtain the finished riboside M product.

2. The method according to claim 1, characterized in that, The amount of protease added is 0.1wt%-2wt% of the total protein content in the biotransformation solution, the temperature during enzymatic hydrolysis is 40℃-65℃, the pH value during enzymatic hydrolysis is 6.5-8.5; and / or, the conditions for high-temperature enzyme inactivation are: incubation at 90℃-100℃ for 15min-30min.

3. The method according to claim 1, characterized in that, The protease includes at least one of alkaline protease, neutral protease, and papain.

4. The method according to claim 1, characterized in that, Before the cooling crystallization, an antisolvent is added to the enzymatic hydrolysis filtrate, the amount of which is 5%-10% of the volume of the enzymatic hydrolysis filtrate; and / or, The antisolvent includes at least one of anhydrous ethanol and isopropanol.

5. The method according to claim 1, characterized in that, When the enzymatic hydrolysis filtrate is subjected to cooling crystallization, it also includes: When the temperature drops to 20℃-30℃, pure seed crystals of ribobadiin M are added to the enzymatic hydrolysis filtrate. The amount of pure seed crystals of ribobadiin M added is 0.5wt%-5wt% of the content of ribobadiin M in the enzymatic hydrolysis filtrate.

6. The method according to claim 1, characterized in that, The cooling crystallization and the heat preservation crystal growth processes are both accompanied by stirring at 50 rpm to 200 rpm; and / or, the heat preservation crystal growth time is 2 h to 6 h.

7. The method according to claim 1, characterized in that, The natural eutectic solvent comprises a hydrogen bond acceptor, a hydrogen bond donor, and deionized water, wherein the molar ratio of the hydrogen bond acceptor, the hydrogen bond donor, and the deionized water is 1:(1-2):(0.5-1).

8. The method according to claim 7, characterized in that, The hydrogen bond acceptor includes at least one of choline chloride and betaine.

9. The method according to claim 7, characterized in that, The hydrogen bond donor includes at least one of glycolic acid, lactic acid, sorbitol, citric acid, and malic acid.

10. The method according to claim 1, characterized in that, The mass-to-volume ratio of the crude crystalline product of riboside M to the natural eutectic solvent is 1 g:(5 mL-12 mL), the stirring and washing temperature is 45℃-55℃, the stirring speed is 200 rpm-300 rpm, and the stirring and washing time is 2 h-4 h; and / or, the rinsing solution is water or ethanol.

Citation Information

Patent Citations

  • A glycosyltransferase mutant for synthesizing rebaudioside M and a synthetic method of rebaudioside M

    CN119265153B